Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Jul;96(1):334–342. doi: 10.1172/JCI118039

Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.

K A Foon 1, M Chakraborty 1, W J John 1, A Sherratt 1, H Köhler 1, M Bhattacharya-Chatterjee 1
PMCID: PMC185205  PMID: 7615803

Abstract

We have generated an IgG1 murine monoclonal anti-idiotype antibody (Ab2) designated 3H1, which mimics a specific epitope on the carcinoembryonic antigen (CEA). Patients with CEA positive tumors are immunologically "tolerant" to CEA. We used 3H1 as a surrogate for CEA for vaccine therapy of 12 patients with advanced colorectal cancer. Each of the patients received a minimum of four intracutaneous injections of aluminum hydroxide precipitated 3H1 at either 1, 2, or 4 mg dosage per injection. 9 of 12 patients demonstrated anti-anti-idiotypic (Ab3) response to 3H1. All nine patients generated specific anti-CEA antibody demonstrated by reactivity with radiolabeled purified CEA; some cases were confirmed by immunoprecipitation of purified CEA. We also demonstrated Ab3 stained both autologous and allogeneic colonic tumors. 7 of 12 patients demonstrated idiotype specific T cell proliferative responses and four also showed T cell proliferation to CEA. Toxicity was limited to local reaction with mild fever and chills. All 12 patients eventually progressed after finishing 4-13 dosages. This is the first report demonstrating that a vaccine therapy is capable of breaking "immune tolerance" to CEA in patients with CEA positive tumors. Future studies will focus on treating patients with minimal residual disease.

Full text

PDF
334

Images in this article

338Image
on p.338
339Image
on p.339
339Image
on p.339
339Image
on p.339
339Image
on p.339
339Image
on p.339
339Image
on p.339
340Image
on p.340
340Image
on p.340

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin E. B., Robins R. A., Baldwin R. W., Durrant L. G. Induction of delayed hypersensitivity to human tumor cells with a human monoclonal anti-idiotypic antibody. J Natl Cancer Inst. 1991 Sep 4;83(17):1245–1248. doi: 10.1093/jnci/83.17.1245. [DOI] [PubMed] [Google Scholar]
  2. Benchimol S., Fuks A., Jothy S., Beauchemin N., Shirota K., Stanners C. P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell. 1989 Apr 21;57(2):327–334. doi: 10.1016/0092-8674(89)90970-7. [DOI] [PubMed] [Google Scholar]
  3. Bhattacharya-Chatterjee M., Chatterjee S. K., Vasile S., Seon B. K., Kohler H. Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3). J Immunol. 1988 Aug 15;141(4):1398–1403. [PubMed] [Google Scholar]
  4. Bhattacharya-Chatterjee M., Mukerjee S., Biddle W., Foon K. A., Köhler H. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. J Immunol. 1990 Oct 15;145(8):2758–2765. [PubMed] [Google Scholar]
  5. Binz H., Meier B., Wigzell H. Induction or elimination of tumor-specific immunity against a chemically-induced rat tumor using auto-anti-idiotypic immunity. Int J Cancer. 1982 Apr 15;29(4):417–423. doi: 10.1002/ijc.2910290410. [DOI] [PubMed] [Google Scholar]
  6. Bona C. A., Heber-Katz E., Paul W. E. Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones. J Exp Med. 1981 Apr 1;153(4):951–967. doi: 10.1084/jem.153.4.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cazenave P. A. Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits. Proc Natl Acad Sci U S A. 1977 Nov;74(11):5122–5125. doi: 10.1073/pnas.74.11.5122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Conry R. M., LoBuglio A. F., Kantor J., Schlom J., Loechel F., Moore S. E., Sumerel L. A., Barlow D. L., Abrams S., Curiel D. T. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 1994 Mar 1;54(5):1164–1168. [PubMed] [Google Scholar]
  9. Dunn P. L., Johnson C. A., Styles J. M., Pease S. S., Dean C. J. Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge. Immunology. 1987 Feb;60(2):181–186. [PMC free article] [PubMed] [Google Scholar]
  10. Durrant L. G., Denton G. W., Jacobs E., Mee M., Moss R., Austin E. B., Baldwin R. W., Hardcastle J. D., Robins R. A. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours. Int J Cancer. 1992 Mar 12;50(5):811–816. doi: 10.1002/ijc.2910500525. [DOI] [PubMed] [Google Scholar]
  11. Forstrom J. W., Nelson K. A., Nepom G. T., Hellström I., Hellström K. E. Immunization to a syngeneic sarcoma by a monoclonal auto-anti-idiotypic antibody. Nature. 1983 Jun 16;303(5918):627–629. doi: 10.1038/303627a0. [DOI] [PubMed] [Google Scholar]
  12. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gaida F. J., Fenger U., Wagener C., Neumaier M. A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen. Int J Cancer. 1992 May 28;51(3):459–465. doi: 10.1002/ijc.2910510320. [DOI] [PubMed] [Google Scholar]
  14. Goldenberg D. M. Monoclonal antibodies in cancer detection and therapy. Am J Med. 1993 Mar;94(3):297–312. doi: 10.1016/0002-9343(93)90062-t. [DOI] [PubMed] [Google Scholar]
  15. Hansen H. J., Goldenberg D. M., Newman E. S., Grebenau R., Sharkey R. M. Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer. 1993 Jun 1;71(11):3478–3485. doi: 10.1002/1097-0142(19930601)71:11<3478::aid-cncr2820711104>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  16. Hansen H. J., LaFontaine G., Newman E. S., Schwartz M. K., Malkin A., Mojzisik K., Martin E. W., Goldenberg D. M. Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen. Clin Chem. 1989 Jan;35(1):146–151. [PubMed] [Google Scholar]
  17. Herlyn D., Wettendorff M., Schmoll E., Iliopoulos D., Schedel I., Dreikhausen U., Raab R., Ross A. H., Jaksche H., Scriba M. Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8055–8059. doi: 10.1073/pnas.84.22.8055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Irvine K., Schlom J. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72. Cancer Immunol Immunother. 1993 May;36(5):281–292. doi: 10.1007/BF01741166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  20. Kaminski M. S., Kitamura K., Maloney D. G., Levy R. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein. J Immunol. 1987 Feb 15;138(4):1289–1296. [PubMed] [Google Scholar]
  21. Kantor J., Irvine K., Abrams S., Kaufman H., DiPietro J., Schlom J. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J Natl Cancer Inst. 1992 Jul 15;84(14):1084–1091. doi: 10.1093/jnci/84.14.1084. [DOI] [PubMed] [Google Scholar]
  22. Kantor J., Irvine K., Abrams S., Snoy P., Olsen R., Greiner J., Kaufman H., Eggensperger D., Schlom J. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate. Cancer Res. 1992 Dec 15;52(24):6917–6925. [PubMed] [Google Scholar]
  23. Kapsopoulou-Dominos K., Anderer F. A. An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract. Clin Exp Immunol. 1979 Jul;37(1):25–32. [PMC free article] [PubMed] [Google Scholar]
  24. Kapsopoulou-Dominos K., Anderer F. A. Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tract. Clin Exp Immunol. 1979 Feb;35(2):190–195. [PMC free article] [PubMed] [Google Scholar]
  25. Kennedy R. C., Dreesman G. R., Butel J. S., Lanford R. E. Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med. 1985 Jun 1;161(6):1432–1449. doi: 10.1084/jem.161.6.1432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Khazaeli M. B., Saleh M. N., Wheeler R. H., Huster W. J., Holden H., Carrano R., LoBuglio A. F. Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response. J Natl Cancer Inst. 1988 Aug 17;80(12):937–942. doi: 10.1093/jnci/80.12.937. [DOI] [PubMed] [Google Scholar]
  27. Koprowski H., Herlyn D., Lubeck M., DeFreitas E., Sears H. F. Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Proc Natl Acad Sci U S A. 1984 Jan;81(1):216–219. doi: 10.1073/pnas.81.1.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Koprowski H., Steplewski Z., Mitchell K., Herlyn M., Herlyn D., Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 1979 Nov;5(6):957–971. doi: 10.1007/BF01542654. [DOI] [PubMed] [Google Scholar]
  29. Kuroki M., Arakawa F., Haruno M., Murakami M., Wakisaka M., Higuchi H., Oikawa S., Nakazato H., Matsuoka Y. Biochemical characterization of 25 distinct carcinoembryonic antigen (CEA) epitopes recognized by 57 monoclonal antibodies and categorized into seven groups in terms of domain structure of the CEA molecule. Hybridoma. 1992 Aug;11(4):391–407. doi: 10.1089/hyb.1992.11.391. [DOI] [PubMed] [Google Scholar]
  30. Kwak L. W., Campbell M. J., Czerwinski D. K., Hart S., Miller R. A., Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med. 1992 Oct 22;327(17):1209–1215. doi: 10.1056/NEJM199210223271705. [DOI] [PubMed] [Google Scholar]
  31. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  32. Lee V. K., Harriott T. G., Kuchroo V. K., Halliday W. J., Hellström I., Hellström K. E. Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6286–6290. doi: 10.1073/pnas.82.18.6286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lejtenyi M. C., Freedman S. O., Gold P. Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system. Cancer. 1971 Jul;28(1):115–120. doi: 10.1002/1097-0142(197107)28:1<115::aid-cncr2820280121>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  34. Lindenmann J. Speculations on idiotypes and homobodies. Ann Immunol (Paris) 1973 May;124(2):171–184. [PubMed] [Google Scholar]
  35. Losman M. J., Monestier M., Hansen H. J., Goldenberg D. M. Baboon anti-idiotype antibodies mimic a carcinoembryonic antigen epitope. Int J Cancer. 1990 Aug 15;46(2):310–314. doi: 10.1002/ijc.2910460228. [DOI] [PubMed] [Google Scholar]
  36. Losman M. J., Novick K. E., Goldenberg D. M., Monestier M. Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody. Int J Cancer. 1994 Feb 15;56(4):580–584. doi: 10.1002/ijc.2910560419. [DOI] [PubMed] [Google Scholar]
  37. Mittelman A., Chen Z. J., Kageshita T., Yang H., Yamada M., Baskind P., Goldberg N., Puccio C., Ahmed T., Arlin Z. Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies. J Clin Invest. 1990 Dec;86(6):2136–2144. doi: 10.1172/JCI114952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mittelman A., Chen Z. J., Yang H., Wong G. Y., Ferrone S. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):466–470. doi: 10.1073/pnas.89.2.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nelson K. A., George E., Swenson C., Forstrom J. W., Hellström K. E. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells. J Immunol. 1987 Sep 15;139(6):2110–2117. [PubMed] [Google Scholar]
  40. Oikawa S., Inuzuka C., Kuroki M., Matsuoka Y., Kosaki G., Nakazato H. Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem Biophys Res Commun. 1989 Oct 16;164(1):39–45. doi: 10.1016/0006-291x(89)91679-3. [DOI] [PubMed] [Google Scholar]
  41. Orefice S., Fossati G., Pietrojusti E., Bonfanti G. Delayed cutaneous hypersensitivity reaction to carcinoembryonic antigen in cancer patients. Tumori. 1982 Dec 31;68(6):473–475. doi: 10.1177/030089168206800604. [DOI] [PubMed] [Google Scholar]
  42. Paxton R. J., Mooser G., Pande H., Lee T. D., Shively J. E. Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family. Proc Natl Acad Sci U S A. 1987 Feb;84(4):920–924. doi: 10.1073/pnas.84.4.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pressman D., Chu T. M., Grossberg A. L. Carcinoembryonic antigen-binding immunoglobulin isolated from normal human serum by affinity chromatography. J Natl Cancer Inst. 1979 Jun;62(6):1367–1371. [PubMed] [Google Scholar]
  44. Primus F. J., Newell K. D., Blue A., Goldenberg D. M. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies. Cancer Res. 1983 Feb;43(2):686–692. [PubMed] [Google Scholar]
  45. Raychaudhuri S., Saeki Y., Chen J. J., Iribe H., Fuji H., Kohler H. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta). J Immunol. 1987 Jul 1;139(1):271–278. [PubMed] [Google Scholar]
  46. Raychaudhuri S., Saeki Y., Chen J. J., Kohler H. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells. J Immunol. 1987 Sep 15;139(6):2096–2102. [PubMed] [Google Scholar]
  47. Robbins P. F., Kantor J. A., Salgaller M., Hand P. H., Fernsten P. D., Schlom J. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res. 1991 Jul 15;51(14):3657–3662. [PubMed] [Google Scholar]
  48. Tao M. H., Levy R. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature. 1993 Apr 22;362(6422):755–758. doi: 10.1038/362755a0. [DOI] [PubMed] [Google Scholar]
  49. Thompson J., Zimmermann W. The carcinoembryonic antigen gene family: structure, expression and evolution. Tumour Biol. 1988;9(2-3):63–83. doi: 10.1159/000217547. [DOI] [PubMed] [Google Scholar]
  50. Tsujisaki M., Hinoda Y., Tokuchi S., Hanzawa Y., Arimura Y., Masuya J., Kitagawa H., Okochi E., Shimamura T., Hamuro J. The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen. J Immunol. 1993 Jan 15;150(2):508–516. [PubMed] [Google Scholar]
  51. Tsujisaki M., Imai K., Tokuchi S., Hanzawa Y., Ishida T., Kitagawa H., Hinoda Y., Yachi A. Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anti-carcinoembryonic antigen antibodies. Cancer Res. 1991 May 15;51(10):2599–2604. [PubMed] [Google Scholar]
  52. Williams W. V., London S. D., Weiner D. B., Wadsworth S., Berzofsky J. A., Robey F., Rubin D. H., Greene M. I. Immune response to a molecularly defined internal image idiotope. J Immunol. 1989 Jun 15;142(12):4392–4400. [PubMed] [Google Scholar]
  53. de Moraes J. Z., Carneiro C. R., Buchegger F., Mach J. P., Lopes J. D. Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system. J Cell Biochem. 1992 Nov;50(3):324–335. doi: 10.1002/jcb.240500313. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES